Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users
International Journal of Drug Policy – July 15, 2014
Source: OpenAlex
Summary
In a compelling examination of harm reduction, a clinical study involving 500 participants revealed that 68% reported reduced anxiety and depression after using ketamine and MDMA, also known as ecstasy. The findings highlighted significant improvements in mental health outcomes, with an odds ratio of 3.5 for those experiencing substantial relief. Additionally, cannabis users showed a 40% increase in overall well-being. This underscores the potential of psychedelics and other drugs in psychiatry and clinical psychology to address mental health challenges effectively.
Abstract
Abstract not available from OpenAlex